Loading insider details...
Beta
Latest Form 4 (Jun 30, 2026): Exercise/Conversion of 68,750 CLYM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 68,750 | n/a |
| Jun 12, 2026 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 5,000 | n/a |
| Jan 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 700,000 | n/a |
| Jul 1, 2025 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 68,750 | n/a |
| Jun 12, 2025 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 31,000 | n/a |
| Jan 15, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 1,150,000 | n/a |
| Jun 27, 2024 | Eliem Therapeutics, Inc. (ELYM) | Grant/Award | 550,000 | n/a |
| Jun 17, 2024 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 50,000 | n/a |
| Jun 7, 2024 | FIBROGEN INC (FGEN) | Grant/Award | 70,000 | n/a |
| Nov 15, 2023 | SYNLOGIC, INC. (SYBX) | Disposition to Issuer | 5,591 | n/a |